SCHEMBL6198282

SCHEMBL6198282

O=Cc1ccc(-c2cc3c4c(c2)cc(F)n4C(=O)CNC3)cc1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.32
DRD1 P21728 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7161035 0.81 HRH3 (0.38)
SCHEMBL7159249 0.79 CYP2A6 (0.33)
SCHEMBL7158056 0.69 CDK8 (0.38)
SCHEMBL6204235 0.67 HTR6 (0.33)
SCHEMBL7159235 0.63 BRD4 (0.40)
SCHEMBL6198446 0.63 GRM2 (0.38)
SCHEMBL25249571 0.60 CYP2A6 (0.50) KIF11DRD1
SCHEMBL4096252 0.60 CYP2A6 (0.50) KIF11DRD1
SCHEMBL411725 0.59 KIF11 (0.52) KIF11DRD1
SCHEMBL2014718 0.58 PRF1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed